Denali Therapeutics Regains Complete Rights to Investigational Treatment DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
Denali plans to proceed medical building of DNL593, which is designed to…
Tag: DNL593
Search
